Income Statement (TTM)
Wai Chun Bio-Technology Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 06-30 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 562 | 568 | 588 | 608 | 552 | 495 | 671 | 774 | 666 | 559 | 464 | 370 | 355 | 341 |
| Change (%) | 0.93 | 3.59 | 3.47 | -9.28 | -10.23 | 35.54 | 15.22 | -13.88 | -16.12 | -16.89 | -20.33 | -3.96 | -4.12 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 509 | 519 | 537 | 556 | 507 | 458 | 611 | 723 | 621 | 518 | 427 | 336 | 319 | 302 |
| Change (%) | 1.84 | 3.59 | 3.46 | -8.82 | -9.67 | 33.54 | 18.31 | -14.16 | -16.50 | -17.60 | -21.36 | -5.00 | -5.27 | |
| % of Revenue | 90.57 | 91.38 | 91.37 | 91.37 | 91.84 | 92.41 | 91.05 | 93.48 | 93.18 | 92.75 | 91.96 | 90.76 | 89.77 | 88.70 |
| Gross Operating Profit | 53 | 49 | 51 | 53 | 45 | 38 | 60 | 50 | 45 | 41 | 37 | 34 | 36 | 39 |
| Change (%) | -7.74 | 3.66 | 3.53 | -14.22 | -16.58 | 60.00 | -16.15 | -9.81 | -10.88 | -7.82 | -8.48 | 6.34 | 5.96 | |
| % of Revenue | 9.43 | 8.62 | 8.63 | 8.63 | 8.16 | 7.59 | 8.95 | 6.52 | 6.82 | 7.25 | 8.04 | 9.24 | 10.23 | 11.30 |
| SG&A | 33 | 35 | 37 | 40 | 38 | 36 | 42 | 39 | 33 | 28 | 33 | 38 | 44 | 49 |
| Change (%) | 6.23 | 7.58 | 7.05 | -5.21 | -5.50 | 17.51 | -7.55 | -14.41 | -16.84 | 19.03 | 15.99 | 14.28 | 12.50 | |
| % of Revenue | 5.80 | 6.10 | 6.34 | 6.56 | 6.85 | 7.21 | 6.25 | 5.02 | 4.99 | 4.94 | 7.08 | 10.31 | 12.26 | 14.39 |
| R&D | ||||||||||||||
| Change (%) | ||||||||||||||
| % of Revenue | ||||||||||||||
| OpEx | 541 | 554 | 575 | 597 | 545 | 494 | 653 | 762 | 654 | 546 | 459 | 373 | 362 | 350 |
| Change (%) | 2.23 | 3.89 | 3.75 | -8.62 | -9.44 | 32.35 | 16.57 | -14.18 | -16.53 | -15.84 | -18.82 | -3.01 | -3.11 | |
| % of Revenue | 96.30 | 97.53 | 97.82 | 98.08 | 98.80 | 99.67 | 97.32 | 98.46 | 98.11 | 97.63 | 98.86 | 100.73 | 101.72 | 102.79 |
| Operating Income | 21 | 14 | 13 | 12 | 7 | 2 | 18 | 12 | 13 | 13 | 5 | -3 | -6 | -10 |
| Change (%) | -32.70 | -8.39 | -9.16 | -43.03 | -75.54 | 1,008.05 | -33.77 | 5.62 | 5.32 | -60.18 | -151.11 | 126.26 | 55.80 | |
| % of Revenue | 3.70 | 2.47 | 2.18 | 1.92 | 1.20 | 0.33 | 2.68 | 1.54 | 1.89 | 2.37 | 1.14 | -0.73 | -1.72 | -2.79 |
| Interest Expense | -7 | -8 | -9 | -10 | -12 | -13 | -14 | -17 | -17 | -18 | -18 | -18 | -19 | -19 |
| Change (%) | 9.84 | 16.09 | 13.86 | 11.29 | 10.14 | 8.96 | 22.48 | 1.18 | 1.17 | 1.11 | 1.10 | 4.31 | 4.13 | |
| % of Revenue | -1.28 | -1.39 | -1.56 | -1.72 | -2.11 | -2.59 | -2.08 | -2.21 | -2.60 | -3.13 | -3.81 | -4.84 | -5.26 | -5.71 |
| Net Income | -3 | -8 | -10 | -13 | -15 | -17 | -14 | -15 | -15 | -14 | -29 | -44 | -48 | -51 |
| Change (%) | 186.73 | 27.92 | 21.83 | 17.04 | 14.56 | -15.64 | 7.45 | -3.55 | -3.69 | 104.20 | 51.03 | 7.83 | 7.26 | |
| % of Revenue | -0.51 | -1.44 | -1.77 | -2.09 | -2.69 | -3.44 | -2.14 | -1.99 | -2.23 | -2.57 | -6.30 | -11.95 | -13.41 | -15.01 |
Source: Capital IQ
